Pharmacokinetics of halofantrine in man: effects of food and dose size.

British Journal of Clinical Pharmacology

Volumn 28, Issue 1, 1989, Pages 71-77

  Milton, KA ^a   Edwards, G ^a   Ward, SA ^a   Orme, ML ^a   Breckenridge, AM ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOFANTRINE;

ADULT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; FOOD; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NORMAL VALUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTIMALARIALS; FASTING; FOOD; HALF-LIFE; HUMAN; MALE; PHENANTHRENES; SUPPORT, NON-U.S. GOV'T;

EID: 0024335624     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1989.tb03507.x     Document Type: Article

References (10)

1. Malaria: treatment efficacy of halofantrine (WR 171, 699) in initial trials in Thailand
2. The treatment and prophylaxis of malaria
3. Introduction of halofantrine for malaria treatment
4. Increased systemic availability of albendazole when taken with a fatty meal
5. The determination of halofantrine and its principal plasma metabolite desbutyl halofantrine in biological fluids by reversed‐phase high performance liquid chromatography
6. Plasma concentrations of mebendazole during treatment of echinococcosis
7. Efficacy of multiple dosehalofantrine in the treatment of chloroquine resistant falciparum malaria in Kenya
8. Clinical pharmacokinetics of antimalarial drugs
9. Influence of food and diet on gastrointestinal drug absorption: a review
10. Clinical trials with halofantrine hydrochloride in Malawi